These findings strongly suggested that miR-320b inhibited proliferation of CRC cells through an inhibition of c-MYC gene function, and that increasing miR-320b expression levels may provide a novel approach for CRC treatments. This evidence concerns the gene MYC and colorectal carcinoma.